What Is Semaglutide?

Semaglutide is a GLP-1 receptor agonist—a medication that mimics the action of glucagon-like peptide-1, a hormone your gut naturally produces after eating. It's FDA-approved under the brand names Ozempic (for type 2 diabetes) and Wegovy (for chronic weight management). Semaglutide works by reducing appetite, slowing gastric emptying, improving insulin sensitivity, and signaling satiety to the brain.

It's one of the most effective weight loss medications ever studied, producing average weight reductions of 15–17% of body weight in clinical trials. As semaglutide use has grown, questions about its effects on reproductive health have naturally followed.

Can Semaglutide Improve Fertility?

For some women—particularly those with obesity or PCOS—semaglutide may actually support fertility rather than harm it. Here's what the research suggests:

Weight Loss and Ovulation

Excess body weight is one of the most common and reversible causes of ovulatory dysfunction. Adipose (fat) tissue is metabolically active—it produces estrogen and contributes to insulin resistance, both of which can disrupt the hormonal signaling necessary for regular ovulation. Research shows that even modest weight loss of 5–10% of body weight can restore ovulatory cycles in women with obesity-related anovulation.

Because semaglutide produces meaningful and sustained weight loss, it can restore or improve ovulation in women whose cycles have been disrupted by excess weight. This is particularly relevant for women who are trying to conceive and haven't had success with lifestyle changes alone.

GLP-1, Insulin Resistance, and PCOS

PCOS affects up to 10% of women of reproductive age and is one of the leading causes of female infertility. Insulin resistance is central to most PCOS cases: elevated insulin stimulates the ovaries to produce excess androgens, suppressing ovulation. By improving insulin sensitivity, semaglutide directly addresses this driver of PCOS-related infertility.

Emerging research on GLP-1 receptor agonists in PCOS is promising:

  • A 2023 study found that women with PCOS treated with semaglutide experienced significant reductions in free testosterone, improved menstrual regularity, and better metabolic markers compared to placebo.
  • Earlier studies on liraglutide (another GLP-1 agonist) found that it improved ovulation rates in overweight women with PCOS, even in the absence of substantial weight loss.
  • GLP-1 receptors are expressed in the ovaries and may play a direct role in follicular development independent of weight effects.

While semaglutide is not approved as a fertility treatment, these findings suggest it may have indirect fertility-supportive effects—particularly in women with insulin-resistant PCOS.

An Important Caveat: Unplanned Pregnancy Risk

Here's a crucial point that often surprises women: because semaglutide can restore ovulation in women who previously weren't ovulating regularly, it can also increase the risk of unintended pregnancy. Women who assumed they were infertile due to PCOS or irregular cycles—and therefore weren't using contraception—have become pregnant unexpectedly after starting GLP-1 therapy.

If you are sexually active and not trying to conceive, use reliable contraception while on semaglutide. And if you're using oral contraceptive pills, be aware that semaglutide's effect on gastric emptying could theoretically reduce pill absorption—many providers recommend using a non-oral method (IUD, implant, or patch) while on GLP-1 therapy.

When to Stop Semaglutide Before Pregnancy

Semaglutide is not recommended for use during pregnancy. Animal studies have shown that GLP-1 receptor agonists can cause fetal harm at high doses, and there is insufficient human data to establish safety in pregnancy. The FDA advises that semaglutide be stopped at least 2 months before a planned pregnancy.

Why 2 Months?

Semaglutide has a half-life of approximately 1 week, meaning it takes about 5 half-lives (roughly 5 weeks) to be substantially cleared from your system. The 2-month timeframe provides a comfortable buffer to ensure the medication is fully eliminated before conception.

Planning Your Timeline

If you are planning to conceive in the near future:

  • Discuss your timeline with your prescribing provider well in advance
  • Plan to stop semaglutide at least 2 months before you begin trying to conceive
  • Use contraception reliably until you are ready to start trying
  • Expect that weight may return after stopping semaglutide—this is normal, and planning can help minimize it

Some women choose to use semaglutide to achieve a healthier weight before pregnancy and then stop the medication well in advance of trying to conceive. This approach may improve pregnancy outcomes: higher pre-pregnancy weight is associated with increased risks of gestational diabetes, preeclampsia, and complications during labor.

What Happens to Weight After Stopping?

One realistic concern: weight regain after stopping semaglutide. Research from the STEP 1 extension trial showed that after stopping semaglutide, participants regained approximately two-thirds of the weight they had lost within one year. This is a biological reality—GLP-1 medications work while you're on them, and the appetite and metabolic changes they produce largely reverse when the medication is stopped.

To minimize weight regain in the period between stopping semaglutide and trying to conceive:

  • Work with a dietitian or nutritionist to establish sustainable eating habits
  • Prioritize strength training to preserve lean muscle mass, which supports metabolic rate
  • Maintain the dietary habits you developed while on semaglutide (high protein, low-GI, anti-inflammatory)
  • Consider whether the 2-month stop period can be minimized by planning the stop date strategically

Alternatives During Pregnancy

Once pregnant, semaglutide should not be used. For women who need support managing blood sugar, weight, or PCOS-related concerns during pregnancy, other approaches are available:

  • Metformin: Commonly used for gestational diabetes and, in some cases, for PCOS during pregnancy. It has a well-established safety profile in pregnancy, though it's used under close medical supervision.
  • Dietary management: A low-glycemic, high-fiber diet remains the first-line approach for managing blood sugar and weight during pregnancy.
  • Inositol: Research suggests myo-inositol supplementation may support insulin sensitivity and pregnancy outcomes in women with PCOS. It's considered safe during pregnancy.
  • Gestational diabetes management: If you develop gestational diabetes, your OB or MFM specialist will guide appropriate treatment, which may include insulin.

Any medication decisions during pregnancy should be made in partnership with your OB-GYN or maternal-fetal medicine specialist.

After Pregnancy: Returning to Semaglutide

Many women wonder whether they can restart semaglutide after delivery or after breastfeeding. GLP-1 medications are not recommended during breastfeeding due to unknown effects on breast milk and the infant. Once you've finished breastfeeding and have clearance from your provider, restarting semaglutide is typically possible.

The postpartum period—often characterized by sleep deprivation, stress, and reduced time for self-care—can be challenging for weight management. Having a clear plan with your healthcare provider for when and how to restart weight management support after pregnancy can make the transition easier.

Key Takeaways

  • Semaglutide may improve fertility in women with obesity or PCOS by promoting weight loss, improving insulin sensitivity, and potentially restoring ovulation.
  • Women with PCOS on semaglutide may ovulate more regularly—use contraception if you're not trying to conceive.
  • Semaglutide must be stopped at least 2 months before a planned pregnancy due to potential fetal risk.
  • Weight regain after stopping is common; plan ahead with dietary habits and exercise to mitigate it.
  • During pregnancy, metformin, dietary changes, and inositol are safer alternatives for managing metabolic concerns.
  • After breastfeeding is complete, restarting semaglutide is an option worth discussing with your provider.

The Bottom Line

The relationship between semaglutide and fertility is complex—and for many women, the effect is positive. By addressing the underlying metabolic dysfunction that disrupts ovulation, GLP-1 therapy may improve the chances of natural conception for women who have struggled with obesity or PCOS. However, it cannot be used during pregnancy, and careful planning is essential. If you're weighing the decision to use semaglutide while thinking about future fertility, a conversation with a knowledgeable women's health provider is the best place to start.